Medicines for Malaria Venture
Lobbying
$180,000 SpentFigures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying On Behalf of Medicines for Malaria Venture
-
Names of Lobbyists
-
Firm Hired Amount Van Scoyoc Assoc $180,000 -
Most Frequently Disclosed Lobbying Issues
- Fed Budget & Appropriations,
- Medical Research & Clin Labs
-
Most Frequently Disclosed Bills
Bill No. Title S.1599 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 H.R.1 Full-Year Continuing Appropriations Act, 2011 H.R.5857 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2013 S.3241 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2013 S.3295 Department of Labor Appropriations Act, 2013
Federal Spending
3 grantsFederal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.
Only grants, contracts and loans with amounts over $1 million are shown.
Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.
Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.
Type | Recipient Name | Year | Agency | Description | Amount |
---|---|---|---|---|---|
grant |
Medicines For Malaria Venture | 2011 | National Institutes Of Health | VALIDATION OF NEW ANTIMALARIAL LEADS | $1,238,884 |
grant |
Medicines For Malaria Venture | 2012 | National Institutes Of Health | VALIDATION OF NEW ANTIMALARIAL LEADS | $1,190,932 |
grant |
Medicines For Malaria Venture | 2011 | National Institutes Of Health | OPTIMIZING NOVEL DIHYDROOROTATE DEHYDROGENASE INHIBITORS FOR TREATING MALARIA | $1,157,642 |